Docket Management
Docket: 00N-1269 - Labeling for Human Prescription Drug/Biologic Products
Comment Number: EC -19

Accepted - Volume 4

Comment Record
Commentor Dr. Karen mCwAY Date/Time 2001-05-16 13:05:33
Organization Kaiser Permanente
Category Health Professional

Comments for FDA General
1. General Comments The proposed changes are much overdue. The inclusion of user-friendly info up front for quick reference, along with more detailed info (along with the index) following would be a very helpful change & could potentially decrease drug-related morbidity & mortality.

EC -19